Literature DB >> 28368436

Are ALK rearrangement variants promising predictive biomarker of ALK tyrosine kinase inhibitors efficacy?

M Duruisseaux1,2,3, A Mc Leer-Florin2,3,4, D Moro-Sibilot1,2,3, J Cadranel5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28368436     DOI： 10.1093/annonc/mdx116

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

Review 1.  Translating Systems Medicine Into Clinical Practice: Examples From Pulmonary Medicine With Genetic Disorders, Infections, Inflammations, Cancer Genesis, and Treatment Implication of Molecular Alterations in Non-small-cell Lung Cancers and Personalized Medicine.

Authors:  Julian Pinsolle; Anne McLeer-Florin; Matteo Giaj Levra; Florence de Fraipont; Camille Emprou; Elisa Gobbini; Anne-Claire Toffart
Journal:  Front Med (Lausanne)       Date:  2019-10-29

2.  Detection of Circulating Tumor Cell Molecular Subtype in Pulmonary Vein Predicting Prognosis of Stage I-III Non-small Cell Lung Cancer Patients.

Authors:  Jingsi Dong; Daxing Zhu; Xiaojun Tang; Xiaoming Qiu; Dan Lu; Bingjie Li; Dan Lin; Qinghua Zhou
Journal:  Front Oncol       Date:  2019-10-29       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.